Table 3.

Effect of Fenfuro on fasting and postprandial plasma sugar levels

Parameters	Groups	Baseline	30-days	60-days	90-days
Fasting plasma sugar levels (mg/dL)	Placebo group	152.96±26.97	148.13±37.72	151.12±48.11	141.81±39.42
	p-value	–	0.192, ns	0.721, ns	0.202, ns
	Treatment group	151.31±24.42	141.19±33.59	135.70±44.87	118.05±25.33
	p-value	–	0.015*	0.007**	0.000**
Postprandial plasma sugar levels (mg/dL)	Placebo group	250.07±75.90	231.05±73.87	226.31±77.97	206.57±72.41
	p-value	–	0.027*	0.012*	0.000**
	Treatment group	251.01±68.88	216.64±74.69	199.38±70.57	174.78±54.90
	p-value	–	0.000**	0.000**	0.000**

A postprandial glucose test is a blood glucose test that determines the amount of glucose in the blood after a meal. Data are expressed as mean±SD.

^{*, **}Significant reduction; ns, not significant.